Medicine and Dentistry
Plasminogen Activator Inhibitor-1
100%
Nonalcoholic Fatty Liver
54%
Fibrosis
45%
Cholesterol
36%
Fatty Liver
36%
Methionine/Choline Deficient Diet
27%
High-Sucrose Diet
27%
Serositis
18%
Diet Induced Obesity
18%
Obesity
18%
Combination Therapy
18%
Gene Deletion
18%
Pathogenesis
9%
Lipid Storage
9%
Steatohepatitis
9%
Development
9%
Fibrinolysis
9%
Long Term Exposure
9%
Sequela
9%
Water-Electrolyte Imbalance
9%
Diet
9%
Pharmacology, Toxicology and Pharmaceutical Science
Plasminogen Activator Inhibitor 1
100%
Nonalcoholic Fatty Liver
54%
Fibrosis
45%
Cholesterol
36%
Fatty Liver
36%
Mouse
36%
Fat
36%
Inflammation
18%
Obesity
18%
Diet Induced Obesity
18%
C57BL 6 Mouse
9%
Pathogenesis
9%
Long Term Exposure
9%
Metabolic Disorder
9%
Sugar
9%
Biochemistry, Genetics and Molecular Biology
Plasminogen Activator Inhibitor-1
100%
Cholesterol
36%
Mouse
36%
Methionine
27%
Choline
27%
Wild Type
18%
Metabolic Disorder
18%
Gene Deletion
18%
Lipid Liver Level
9%
Small Molecule
9%
C57BL 6 Mouse
9%
Development
9%
Lipid Storage
9%
Fibrinolysis
9%
Genetics
9%
Neuroscience
Plasminogen Activator Inhibitor-1
100%
Cholesterol
36%
Fat
36%
Sugar
36%
Methionine
27%
Choline
27%
Immunology and Microbiology
Steatohepatitis
54%
Mouse
36%
Wild Type
18%
Gene Deletion
18%
Inflammation
18%
C57BL 6 Mouse
9%
Lipid Storage
9%
Fibrinolysis
9%
Development
9%
Liver
9%
Lipid Liver Level
9%